The Transient Nature of Bunyamwera Orthobunyavirus NSs Protein Expression: Effects of Increased Stability of NSs Protein on Virus Replication

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  van Knippenberg, Ingeborg ^a,c   Fragkoudis, Rennos ^b,d   Elliott, Richard M ^a,c  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; INTERFERON; LYSINE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BUNYAMWERA ORTHOBUNYAVIRUS; CONTROLLED STUDY; INSECT CELL; MAMMAL CELL; MOSQUITO; MOUSE; NONHUMAN; ORTHOBUNYAVIRUS; ORTHOBUNYAVIRUS INFECTION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; UBIQUITINATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE;

AEDES; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BUNYAMWERA VIRUS; CELLS, CULTURED; DNA FRAGMENTATION; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SEQUENCE ANALYSIS, DNA; UBIQUITINATION; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84877291633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064137     Document Type: Article

References (49)

1. Nichol ST (2001) Ch49- Bunyaviruses. 4(null) ed. Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, et al., editors Lippincott Williams & Wilkins Publishers. 24 p.
2. Garigliany M-M, Bayrou C, Kleijnen D, Cassart D, Jolly S, et al. (2012) Schmallenberg virus: A new Shamonda/Sathuperi-like virus on the rise in Europe. Antiviral Research 95: 82-87 doi:10.1016/j.antiviral.2012.05.014.
3. Elliott RM, Blakqori G (2011) Molecular biology of orthobunyaviruses. Plyusnin A, Elliott RM, editors Caister Academic Press.
4. Bridgen A, Weber F, Fazakerley JK, Elliott RM, (2001) Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA 98: 664-669 doi:10.1073/pnas.98.2.664.
5. Elliott RM, Weber F, (2009) Bunyaviruses and the Type I Interferon System. Viruses 1: 1003-1021 doi:10.3390/v1031003.
6. Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, et al. (2002) Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76: 7949-7955.
7. Colón-Ramos DA, Irusta PM, Gan EC, Olson MR, Song J, et al. (2003) Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell 14: 4162-4172 doi:10.1091/mbc.E03-03-0139.
8. Hart TJ, Kohl A, Elliott RM, (2009) Role of the NSs Protein in the Zoonotic Capacity of Orthobunyaviruses. Zoonoses and Public Health 56: 285-296 doi:10.1111/j.1863-2378.2008.01166.x.
9. Kohl A, Clayton RF, Weber F, Bridgen A, Randall RE, et al. (2003) Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol 77: 7999-8008.
10. Thomas D, Blakqori G, Wagner V, Banholzer M, Kessler N, et al. (2004) Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279: 31471-31477 doi:10.1074/jbc.M400938200.
11. Weber F, Dunn EF, Bridgen A, Elliott RM, (2001) The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system. Virology 281: 67-74 doi:10.1006/viro.2000.0774.
12. Scallan MF, Elliott RM, (1992) Defective RNAs in mosquito cells persistently infected with Bunyamwera virus. J Gen Virol 73 (Pt 1): 53-60.
13. van Knippenberg I, Carlton-Smith C, Elliott RM, (2010) The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. Journal of General Virology 91: 2002-2006 doi:10.1099/vir.0.021774-0.
14. Kerscher O, Felberbaum R, Hochstrasser M, (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22: 159-180 doi:10.1146/annurev.cellbio.22.010605.093503.
15. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, et al. (2007) Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 81: 3428-3436 doi:10.1128/JVI.02303-06.
16. Hilton L, Moganeradj K, Zhang G, Chen Y-H, Randall RE, et al. (2006) The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 80: 11723-11732 doi:10.1128/JVI.01145-06.
17. Precious B, Young DF, Andrejeva L, Goodbourn S, Randall RE, (2005) In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 86: 151-158 doi:10.1099/vir.0.80263-0.
18. Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall RE, (2005) Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79: 13434-13441 doi:10.1128/JVI.79.21.13434-13441.2005.
19. Seago J, Goodbourn S, Charleston B, (2010) The classical swine fever virus Npro product is degraded by cellular proteasomes in a manner that does not require interaction with interferon regulatory factor 3. J Gen Virol 91: 721-726 doi:10.1099/vir.0.015545-0.
20. Young JA, Sermwittayawong D, Kim H-J, Nandu S, An N, et al. (2011) Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production. Journal of Biological Chemistry 286: 6521-6531 doi:10.1074/jbc.M110.172288.
21. Delboy MG, Roller DG, Nicola AV, (2008) Cellular Proteasome Activity Facilitates Herpes Simplex Virus Entry at a Postpenetration Step. J Virol 82: 3381-3390 doi:10.1128/JVI.02296-07.
22. Khor R, McElroy LJ, Whittaker GR, (2003) The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4: 857-868.
23. Wang H, Bauzon F, Ji P, Xu X, Sun D, et al. (2010) Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Nat Genet 42: 83-88 doi:10.1038/ng.498.
24. Zhadina M, McClure MO, Johnson MC, Bieniasz PD, (2007) Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci USA 104: 20031-20036 doi:10.1073/pnas.0708002104.
25. Contin R, Arnoldi F, Mano M, Burrone OR, (2011) Rotavirus replication requires a functional proteasome for effective assembly of viroplasms. J Virol 85: 2781-2792 doi:10.1128/JVI.01631-10.
26. Fernandez-Garcia M-D, Meertens L, Bonazzi M, Cossart P, Arenzana-Seisdedos F, et al. (2011) Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J Virol 85: 2980-2989 doi:10.1128/JVI.02483-10.
27. López T, Silva-Ayala D, López S, Arias CF, (2011) Replication of the rotavirus genome requires an active ubiquitin-proteasome system. J Virol 85: 11964-11971 doi:10.1128/JVI.05286-11.
28. Chen YT, Lin CH, Ji WT, Li SK, Liu HJ, (2008) Proteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells. J Virol Methods 151: 95-100 doi:10.1016/j.jviromet.2008.03.016.
29. Liu J, Wei L, Jiang T, Shi L, Wang J, (2007) Reduction of infectious bursal disease virus replication in cultured cells by proteasome inhibitors. 35: 719-727 doi:10.1007/s11262-007-0147-3.
30. Lupfer C, Pastey MK, (2010) Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132. Virus Res 149: 36-41 doi:10.1016/j.virusres.2009.12.010.
31. Neznanov N, Dragunsky EM, Chumakov KM, Neznanova L, Wek RC, et al. (2008) Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS ONE 3: e1887 doi:10.1371/journal.pone.0001887.
32. Raaben M, Posthuma CC, Verheije MH, Lintelo Te EG, Kikkert M, et al. (2010) The Ubiquitin-Proteasome System Plays an Important Role during Various Stages of the Coronavirus Infection Cycle. J Virol 84: 7869-7879 doi:10.1128/JVI.00485-10.
33. Teale A, Campbell S, Van Buuren N, Magee WC, Watmough K, et al. (2008) Orthopoxviruses Require a Functional Ubiquitin-Proteasome System for Productive Replication. J Virol 83: 2099-2108 doi:10.1128/JVI.01753-08.
34. Brower CS, Sato S, Tomomori-Sato C, Kamura T, Pause A, et al. (2002) Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Proc Natl Acad Sci USA 99: 10353-10358 doi:10.1073/pnas.162424199.
35. Léonard VHJ, Kohl A, Hart TJ, Elliott RM, (2006) Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol 80: 9667-9675 doi:10.1128/JVI.00822-06.
36. Ohh M, Kim WY, Moslehi JJ, Chen Y, Chau V, et al. (2002) An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep 3: 177-182 doi:10.1093/embo-reports/kvf028.
37. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, et al. (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458: 732-736 doi:10.1038/nature07884.
38. Yang Y, Kitagaki J, Dai RM, Tsai YC, Lorick KL, et al. (2007) Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics. Cancer Res 67: 9472-9481 doi:10.1158/0008-5472.CAN-07-0568.
39. Patel AH, Elliott RM, (1992) Characterization of Bunyamwera virus defective interfering particles. J Gen Virol 73 (Pt 2): 389-396.
40. Killip MJ, Young DF, Precious BL, Goodbourn S, Randall RE, (2012) Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesis. Journal of General Virology 93: 299-307 doi:10.1099/vir.0.037531-0.
41. Lowen AC, Boyd A, Fazakerley JK, Elliott RM, (2005) Attenuation of bunyavirus replication by rearrangement of viral coding and noncoding sequences. J Virol 79: 6940-6946 doi:10.1128/JVI.79.11.6940-6946.2005.
42. Coux O, Tanaka K, Goldberg AL, (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847 doi:10.1146/annurev.bi.65.070196.004101.
43. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479 doi:10.1146/annurev.biochem.67.1.425.
44. Szemiel AM, Failloux A-B, Elliott RM, (2012) Role of Bunyamwera Orthobunyavirus NSs Protein in Infection of Mosquito Cells. PLoS Negl Trop Dis 6: e1823 doi:10.1371/journal.pntd.0001823.g008.
45. Buchholz UJ, Finke S, Conzelmann K-K, (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251-259.
46. Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, et al. (2009) CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383: 6-11 doi:10.1016/j.virol.2008.10.002.
47. Bridgen A, Elliott RM, (1996) Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci USA 93: 15400-15404.
48. Lowen AC, Noonan C, McLees A, Elliott RM, (2004) Efficient bunyavirus rescue from cloned cDNA. Virology 330: 493-500 doi:10.1016/j.virol.2004.10.009.
49. Fragkoudis R, Breakwell L, McKimmie C, Boyd A, Barry G, et al. (2007) The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons. J Gen Virol 88: 3373-3384 doi:10.1099/vir.0.83191-0.